Skip to content

Health— page 26

health

China’s drug regulator accepts Novo Nordisk’s application for oral Wegovy

SHANGHAI, Aug 27 (Reuters) – Novo Nordisk said on Thursday that China’s drug regulator had accepted its application to sell the oral version of its GLP-1 weight-loss drug Wegovy, as the Danish drugmaker seeks to catch up with rival Eli Lilly in the world’s second-largest pharmaceutical market. Novo,

· SRN Health
China’s drug regulator accepts Novo Nordisk’s application for oral Wegovy
health

Agilent raises annual profit forecast on improving lab tools demand

By Bageshri Banerjee Aug 26 (Reuters) – Agilent Technologies raised its annual profit forecast on Wednesday, betting on improving demand for its medical tools and equipment used in lab research and drug development. • Demand conditions are improving for U.S. life sciences and laboratory-equipment co

· SRN Health
health

FDA approves landmark pancreatic cancer drug that’s shown to improve survival

WASHINGTON (AP) — The Food and Drug Administration on Wednesday approved a groundbreaking new drug for advanced pancreatic cancer, offering U.S. patients a more effective treatment against one of the deadliest types of cancer. FDA officials gave expedited approval to the first-of-a-kind pill, called

· SRN Health
FDA approves landmark pancreatic cancer drug that’s shown to improve survival
health

Revolution’s lifesaving pancreatic cancer drug wins speedy FDA approval

By Padmanabhan Ananthan and Christy Santhosh Aug 26 (Reuters) – The U.S. FDA has approved Revolution Medicines’ groundbreaking pancreatic cancer drug after it was shown to double the survival rate of patients with advanced disease in a large trial, offering new hope to those with the deadly cancer.

· SRN Health
Revolution’s lifesaving pancreatic cancer drug wins speedy FDA approval
health

WHO says Ebola outbreak in Uganda is over, as cases rise in Congo

By Jennifer Rigby LONDON, Aug 26 (Reuters) – The outbreak of the Bundibugyo strain of Ebola in Uganda is over but it is not under control in neighbouring Democratic Republic of Congo, a World Health Organization official told a briefing on Wednesday. The all-clear for Uganda follows a declaration on

· SRN Health
WHO says Ebola outbreak in Uganda is over, as cases rise in Congo
health

West Nile virus infection causes one death in the Netherlands

AMSTERDAM, Aug 26 (Reuters) – A person has died in a Dutch hospital after contracting the West Nile virus in the Netherlands, the country’s public health institution RIVM said on Wednesday. The RIVM reported last week the first West Nile virus infection ​contracted in the Netherlands since 2020 and

· SRN Health
health

Boston Scientific hit by cyberattack, global operations affected

By Sahil Pandey Aug 26 (Reuters) – Boston Scientific said on Wednesday that a cybersecurity incident had disrupted global operations, including some information systems used to process and ship customer orders. The medical device maker said it detected the incident on August 25 and had activated inc

· SRN Health
Boston Scientific hit by cyberattack, global operations affected
health

Medicover India hospitals to be profitable in 18 months, eyes 20-25% margins

By Rishika Sadam HYDERABAD, Aug 26 (Reuters) – Swedish healthcare provider Medicover’s India business is on track to have all 25 hospitals in its network become profitable within 18 months, driven by rising occupancy and demand for specialised care, a top executive said on Wednesday. Earlier this mo

· SRN Health
health

Cyclosporiasis cases in US climb to 17,180, CDC says

Aug 25 (Reuters) – The Centers for Disease Control and Prevention on Tuesday reported 17,180 confirmed cases of cyclosporiasis in the United States, an increase of 1,464 cases from a week ago. Here are some details: • The CDC said it has received reports of 17,180 confirmed cases across 48 states pl

· SRN Health
Cyclosporiasis cases in US climb to 17,180, CDC says
health

Bristol Myers ends blood cancer drug deal with cell therapy maker Cellares

Aug 25 (Reuters) – Bristol Myers Squibb has ended its partnership with cell therapy startup Cellares to expand the manufacturing of its personalized blood cancer therapy, a company spokesperson told Reuters on Tuesday. Bristol Myers determined that Cellares’ cell therapy manufacturing platform, Cell

· SRN Health
Bristol Myers ends blood cancer drug deal with cell therapy maker Cellares
health

Record salmonella outbreak in Belgium infects at least 306

BRUSSELS, Aug 25 (Reuters) – A record salmonella outbreak in a Belgian chicken farm has infected at least 306 people after they ate eggs, the food safety agency said on Tuesday. The agency said those who developed symptoms had been contaminated by a strain found at the farm, though many more may hav

· SRN Health
Record salmonella outbreak in Belgium infects at least 306
health

More US employers to drop weight-loss drugs in 2027, as healthcare costs increase

By Amina Niasse NEW YORK, Aug 25 (Reuters) – About 14% of employers in the United States have already or plan to drop GLP-1 drugs in 2027, as companies see rising healthcare costs, according to a survey released on Tuesday by the Business Group on Health. Healthcare costs are set to increase 9.2% if

· SRN Health
More US employers to drop weight-loss drugs in 2027, as healthcare costs increase
health

How to reset your child’s sleep schedule for back-to-school season

NEW YORK (AP) — After a summer of vacations and late nights, it’s time to set those back-to-school alarms. A good night’s sleep helps students stay focused and attentive in class. Experts say it’s worth easing kids back into a routine with the start of a new school year. “We don’t say ‘ get good sle

· SRN Health
How to reset your child’s sleep schedule for back-to-school season
health

McKesson strikes $2.25 billion Precision Medicine deal in clinical research bets

By Sahil Pandey and Siddhi Mahatole Aug 25 (Reuters) – McKesson said on Tuesday it would buy privately held Precision Medicine Group in a deal valued at about $2.25 billion, as part of a years-long effort to strengthen its higher-growth businesses. The U.S. drug distributor has been reshaping its po

· SRN Health
health

US FDA expands approval for J&J’s drug for rare blood disorder

(Fixes hyperlink in paragraph 10) By Kunal Das and Padmanabhan Ananthan Aug 24 (Reuters) – The U.S. Food and Drug Administration has approved the expanded use of Johnson & Johnson’s drug to treat a rare blood disorder, the company said on Monday. The approval makes Imaavy the first treatment cleared

· SRN Health
US FDA expands approval for J&J’s drug for rare blood disorder